Join Growin Stock Community!

立萬利3054.TW Overview

TW StockFoods
(No presentation for 3054)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

立萬利(3054)Overall Performance

立萬利(3054)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

立萬利(3054) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

立萬利(3054)Key Information

立萬利(3054)Profile

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin Q10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat's milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.

立萬利(3054)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.96
PE Ratio (TTM)
19.25
Forward PE
-
PS Ratio (TTM)
24.25
PB Ratio
2.88
Price-to-FCF
131.59
METRIC
VALUE
vs. INDUSTRY
Gross Margin
31.15%
Net Margin
125.97%
Revenue Growth (YoY)
26.61%
Profit Growth (YoY)
87.73%
3-Year Revenue Growth
32.93%
3-Year Profit Growth
81.40%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.96
PE Ratio (TTM)
19.25
Forward PE
-
PS Ratio (TTM)
24.25
PB Ratio
2.88
Price-to-FCF
131.59
Gross Margin
31.15%
Net Margin
125.97%
Revenue Growth (YoY)
26.61%
Profit Growth (YoY)
87.73%
3-Year Revenue Growth
32.93%
3-Year Profit Growth
81.40%
3054.TW logo

3054

立萬利

37.75D

-10.46%

(-0.10)

  • When is 3054's latest earnings report released?

    The most recent financial report for 立萬利 (3054) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3054's short-term business performance and financial health. For the latest updates on 3054's earnings releases, visit this page regularly.

  • Where does 3054 fall in the P/E River chart?

    According to historical valuation range analysis, 立萬利 (3054)'s current price-to-earnings (P/E) ratio is 16.54, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 3054?

    According to the latest financial report, 立萬利 (3054) reported an Operating Profit of -45.08M with an Operating Margin of -188.65% this period, representing a decline of 319.53% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 3054's revenue growth?

    In the latest financial report, 立萬利 (3054) announced revenue of 23.9M, with a Year-Over-Year growth rate of 38.23%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 3054 have?

    At the end of the period, 立萬利 (3054) held Total Cash and Cash Equivalents of 146.37M, accounting for 0.13 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3054 go with three margins increasing?

    In the latest report, 立萬利 (3054) did not achieve the “three margins increasing” benchmark, with a gross margin of 62.07%%, operating margin of -188.65%%, and net margin of 438.1%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3054's profit trajectory and future growth potential.

  • Is 3054's EPS continuing to grow?

    According to the past four quarterly reports, 立萬利 (3054)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.3. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 3054?

    立萬利 (3054)'s Free Cash Flow (FCF) for the period is 381K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 54.1% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.